Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chemocentryx Inc (CCXI)

Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 60.88 (-0.44%)
VRTX : 400.76 (-1.02%)
IBB : 127.76 (-0.20%)
CCXI : 51.99 (+0.06%)
CTLT : 55.95 (-0.14%)
XBI : 83.94 (-0.89%)
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Smart Beta ETF report for PBE

PBE : 60.88 (-0.44%)
VRTX : 400.76 (-1.02%)
IBB : 127.76 (-0.20%)
CCXI : 51.99 (+0.06%)
CTLT : 55.95 (-0.14%)
XBI : 83.94 (-0.89%)
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

Smart Beta ETF report for XBI

XBI : 83.94 (-0.89%)
IBB : 127.76 (-0.20%)
CCXI : 51.99 (+0.06%)
GBT : 68.49 (+0.01%)
FBT : 145.35 (+0.26%)
KRTX : 329.83 (+0.03%)
Should You Invest in the SPDR S&P Biotech ETF (XBI)?

Sector ETF report for XBI

XBI : 83.94 (-0.89%)
IBB : 127.76 (-0.20%)
CCXI : 51.99 (+0.06%)
GBT : 68.49 (+0.01%)
FBT : 145.35 (+0.26%)
KRTX : 329.83 (+0.03%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 60.88 (-0.44%)
VRTX : 400.76 (-1.02%)
IBB : 127.76 (-0.20%)
CCXI : 51.99 (+0.06%)
CTLT : 55.95 (-0.14%)
XBI : 83.94 (-0.89%)
AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc. (NASDAQ:...

AMGN : 273.01 (-0.19%)
CCXI : 51.99 (+0.06%)
Is ChemoCentryx (CCXI) Stock Outpacing Its Medical Peers This Year?

Here is how ChemoCentryx (CCXI) and Eiger BioPharmaceuticals (EIGR) have performed compared to their sector so far this year.

CCXI : 51.99 (+0.06%)
EIGR : 1.7250 (-9.21%)
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Smart Beta ETF report for PBE

PBE : 60.88 (-0.44%)
VRTX : 400.76 (-1.02%)
IBB : 127.76 (-0.20%)
CCXI : 51.99 (+0.06%)
CTLT : 55.95 (-0.14%)
XBI : 83.94 (-0.89%)
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

Smart Beta ETF report for XBI

XBI : 83.94 (-0.89%)
IBB : 127.76 (-0.20%)
CCXI : 51.99 (+0.06%)
GBT : 68.49 (+0.01%)
FBT : 145.35 (+0.26%)
KRTX : 329.83 (+0.03%)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CYBE, CCXI, AVLR

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CYBE : 54.00 (unch)
CCXI : 51.99 (+0.06%)
AVLR : 93.48 (+0.03%)

Barchart Exclusives

3 Dividend Aristocrats to Buy on Every Dip
As markets get wobbly, here are three Dividend Aristocrats to add a little stability to any portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar